ArticleEuropean heart journal2021

Increasing the prescription rate of β-blockers is beneficial for patients with chronic obstructive pulmonary and cardiovascular disease.

Yan-Li Yang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.